News

Cutera Expands truFlex Applications for Rehabilitation and Wellness

Cutera Expands truFlex Applications for Rehabilitation and Wellness

Cutera Expands truFlex Applications to Enhance Patient Wellness

The next evolution of truFlex strengthens its role as a versatile solution for rehabilitation, opening new avenues in functional strength for the abdomen, arms, calves, glutes, and thighs.

Based in California, Cutera, Inc. is a prominent name in aesthetic and dermatological solutions. The company has just announced a significant development: the U.S. Food and Drug Administration (FDA) has granted expanded indications for its truFlex muscle stimulation technology. This new clearance goes beyond aesthetic applications, introducing additional rehabilitative and therapeutic uses that benefit not only the arms and calves but also a wider array of patients seeking rehabilitation.

Dr. Edward Alvarez, the CEO and Founder of Restimulate Health, expressed enthusiasm for these advancements: "The new truFlex indications signify a transformative step in muscle rehabilitation and functional strength development. The precision and customizable features of truFlex make it an outstanding modality for aiding patients throughout their wellness journeys. I am excited about the positive changes this brings for those I care for in my practice."

The newly expanded indications include:

  • Strengthening and firming of arms and calves
  • Muscle spasm relaxation
  • Prevention of disuse atrophy
  • Enhancement of local blood circulation
  • Muscle re-education
  • Maintaining or improving the range of motion
  • Immediate post-surgical stimulation to mitigate venous thrombosis
  • Support for rehabilitative muscle excitation in legs and arms
  • Adjunctive therapy for medical conditions (to be supervised by a healthcare professional)

According to Taylor Harris, CEO of Cutera, muscle wellness and rehabilitation are pivotal growth areas in medical technology right now. He notes, "These new clearances mark a milestone in our mission as a company to enhance patient lives with advanced solutions that satisfy both aesthetic and therapeutic demands. By bringing truFlex into rehabilitation and recovery, we are presenting providers with greater opportunities to support patients across various care settings."

Initially launched in 2019, truFlex utilizes proprietary Multi-Directional Stimulation (MDS) technology, which enables controlled muscle contractions in designated muscle groups. This technology incorporates customized energy delivery through applicators tailored to each patient's unique body shape or treatment areas. With the new FDA clearance, Cutera is poised to collaborate with physicians, rehabilitation specialists, and healthcare providers to enhance patient outcomes and support overall wellness.

For those interested in truFlex, further details can be found through Cutera. Patients seeking to explore truFlex services can access valuable resources online. Additionally, the company emphasizes the importance of medical supervision during treatment procedures to ensure safety and effectiveness.

About Cutera, Inc.

Cutera stands out as a leading provider of aesthetic and dermatological solutions globally. With over 25 years of experience, the company is committed to improving lives through innovative medical technologies that prioritize scientific advancement and partnership. Those interested in Cutera products are encouraged to reach out directly by calling their dedicated support line. More information is available through their official website.

Important Safety Information about truFlex

Indications for Use: truFlex is designed to enhance abdominal tone, strengthen abdominal muscles, and foster a firmer abdominal structure. It is also effective for toning and firming various muscle groups, muscle re-education, prevention of atrophy, and adjunctive therapy for medical conditions under professional supervision.

Potential Side Effects: Treatment may lead to transient side effects such as increased heart rate, skin irritation, discomfort, and muscle soreness. Various uncommon adverse events could also occur.

Contraindications: Patients with cardiac devices, certain medical conditions, or specific physical impairments should avoid truFlex treatments. Safety assessments before initiating treatment are critical to ensure patient well-being.

Precautions: It is essential to consult healthcare professionals regarding underlying health conditions or risks before treatment. Patient feedback is critical for determining optimal treatment levels and preventing potential reactions.

Before starting truFlex treatment, thorough evaluations for undiagnosed conditions such as hernias are necessary. Consultations with physicians are recommended for patients with a history of hernias or recent surgeries. Patients are advised to avoid strenuous activities before and after treatments to promote recovery and prevent complications.

Frequently Asked Questions

What is truFlex technology used for?

truFlex technology is designed for muscle strengthening, rehabilitation, and wellness support, allowing for improved muscle tone and functionality.

How has truFlex been expanded?

The FDA has granted truFlex expanded indications for therapeutic applications through muscle stimulation across various body areas, enhancing treatment options.

Who can benefit from truFlex treatments?

Patients needing rehabilitation, muscle strength training, or therapeutic support for certain medical conditions can significantly benefit from truFlex treatments.

What is the importance of medical supervision during truFlex treatments?

Medical supervision ensures patient safety and the appropriateness of treatment, particularly for individuals with underlying health conditions.

How can practitioners obtain more information about truFlex?

Practitioners can reach out to Cutera directly or visit their official website for comprehensive information on truFlex products and training opportunities.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Horowitz's $150M Boost for Nevada's First Children's Hospital

Updated Category News Views 97

Big Bucks and Bigger Hearts Boost Pediatric Care in Nevada The world isn't exactly short on folks looking to make a buck, but every so often, someone comes along and wants to make a difference instead. Enter Felicia and Ben Horowitz, handing over a staggering $150 million to Intermountain Health. This isn’t your garden-variety gift—it’s aimed at getting Nevada on...

Continue Reading
UCB's Endowment Marks New Era in Medicine Evaluation

Updated Category News Views 60

Stepping into a New Chapter for Medicine Evaluation UCB's latest move smacks of a strategic vision that's not just about immediate returns—it's a long game in pharmacoepidemiology. You don't see investors lining up for this news, but this chair at Brigham and Women's is bigger than it looks. By establishing the Emmanuel Janssen Endowed Chair, UCB is underpinning the...

Continue Reading
Steady Income Boosts FHLBank Boston's Growth Q3 2026

Updated Category News Views 50

The Federal Home Loan Bank of Boston dropped their third-quarter results for 2026 like a hot smokestack, and let me tell you, it's a mixed bag of cautious optimism and steady progression. It's essentially proof that slow and steady might just win the race—or at least keep you in the running. Stable and Steady Headway Taking a peek under the hood, FHLBank Boston made a...

Continue Reading
Wisconsin Brats Clash with Florida Citrus in Marketing Showdown

Updated Category News Views 14

A Juicy Rivalry with Sweet and Savory Stakes You ever catch yourself watching state pride turn into a marketing showdown? That's what's cookin' with Wisconsin's Johnsonville and Florida's Natural, and believe me, this isn't just about what’s on your plate. Forget the foam fingers, here it's all about the brats and the OJ. It's like the Packers versus the Dolphins, but...

Continue Reading
Apalutamide Boosts Outlook for Prostate Cancer Treatment

Updated Category News Views 28

Fresh Findings on High-Risk Prostate Cancer Treatments In an industry that often feels like a game of chess, Johnson & Johnson's recent news unveils another one of their strategic moves with the announcement of breakthrough results from their Phase 3 PROTEUS substudy. Turns out, ERLEADA®, their apalutamide treatment, isn't just another pawn; it's a potential...

Continue Reading
Patrick Ta Beauty Adds New Leadership to Expand Growth

Updated Category News Views 36

Angela Simpson and Carolyne Rapp Join the Ranks In the fast-paced world of beauty, where trends shift faster than a day trader’s mood, Patrick Ta Beauty is shaking things up with some heavyweight hires. Angela Simpson steps in as Chief Marketing Officer, and Carolyne Rapp takes the reins as Vice President of Creative. Maybe it’s just me, but when a brand ropes in pros...

Continue Reading
Lunit, Summit Tackle Tumor Analysis with AI Platform

Updated Category News Views 168

Amid whispers of AI revolutionizing every industry, let's zero in on its latest pit stop—oncology R&D. Lunit, shaking hands with Summit Therapeutics, plans to bring artificial intelligence into the tumor microenvironment analysis game, thanks to the Lunit SCOPE IO platform. This isn't just another lab experiment; it's a step towards redefining how we understand cancer's...

Continue Reading
Hyperliquid Reports Q3 2026 Results with Webcast Insights

Updated Category News Views 74

Unlocking Hyperliquid’s Third Quarter Performance It's time to grab your investing gear because Hyperliquid Strategies Inc is ready to spill the beans on their Q3 2026 performance. The digital asset treasury focused on the hyperventilating HYPE token—fined-tuned to serve US and institutional investors—is broadcasting a live webcast on November 5, 2026. Mark your...

Continue Reading
Taiwan Fuses Ancient TCM with Modern Bio Tech in 2026

Updated Category News Views 57

The Dynamic Fusion of Heritage and Innovation When you think about it, mixing centuries-old herbal wisdom with today's cutting-edge biotech might sound like a plot twist, but that's exactly what's cooking in Taiwan. Over at SupplySide Global 2026 in Las Vegas, Taiwan's got something more than just traditional medicine to flaunt; it's showcasing an impressive fusion of...

Continue Reading
Veterans Find Community and Wellness at Orland Hills Bash

Updated Category News Views 16

A Celebration of Veterans and Community Orland Hills is set to light up with a unique Veterans Day Bash on November 1, 2026. This isn't just your run-of-the-mill community gathering; it's an event that brings together veterans from all around for a day packed with resources, education, and a chance to connect with kindred spirits—all thanks to the collaboration between...

Continue Reading

Top 5 Most Recently Viewed Articles

2026 Best Buddies Challenge Hits $4M For Inclusion

Updated Category News Views 7

A Record-Breaking Year for Best Buddies Everyone loves a good underdog story, and every now and then, you get one that really hits home. The 27th Annual Best Buddies Challenge in Hyannis Port did exactly that, raking in a whopping $4 million and drawing a crowd of nearly 1,000 participants. The event serves as both a fundraiser and a community builder, spotlighting its...

Continue Reading
MSP Recovery Implements Reverse Stock Split for Compliance

Updated Category News Views 239

MSP Recovery Announces a Reverse Stock Split MSP Recovery, Inc. (NASDAQ: MSPR), a leader in Medicare, Medicaid, and secondary payer reimbursement recovery, recently announced a reverse stock split of its Class A common stock at a ratio of 1-for-7. This strategic move aims to ensure compliance with Nasdaq's minimum bid price requirement. Details of the Stock Split The...

Continue Reading
The Value of a $1000 Investment in Primerica Over 10 Years

Updated Category News Views 127

Understanding Primerica's Growth Over the Last Decade Primerica Inc (NYSE: PRI) has shown remarkable performance, outperforming the market by an annualized rate of 8.02%. This impressive rate results in an average annual return of 19.51% for the investors over the past ten years. As of now, the company has a market valuation of approximately $8.63 billion, indicating...

Continue Reading
Innovative G-Rex Grants Propel Cell Therapy Manufacturing Growth

Updated Category News Views 161

Innovative G-Rex Grants Propel Cell Therapy Manufacturing Growth ScaleReady, in partnership with Wilson Wolf Manufacturing and Bio-Techne Corporation (NASDAQ: TECH), has announced an exciting initiative aimed at enhancing cell and gene therapy manufacturing. Eight G-Rex Grants, amounting to nearly $2 million, have been awarded to distinguished recipients within the...

Continue Reading